Intervention against hypertension in the next generation programmed by developmental hypoxia

Kirsty L. Brain, Beth J. Allison, Youguo Niu, Christine M. Cross, Nozomi Itani, Andrew D. Kane, Emilio A. Herrera, Katie L. Skeffington, Kimberley J. Botting, Dino A. Giussani

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans share similar precocial developmental milestones in cardiovascular anatomy and physiology. We tested the hypothesis in sheep that maternal treatment with antioxidants protects against fetal growth restriction and programmed hypertension in adulthood in gestation complicated by chronic fetal hypoxia, the most common adverse consequence in human pregnancy. Using bespoke isobaric chambers, chronically catheterized sheep carrying singletons underwent normoxia or hypoxia (10% oxygen [O 2 ]) ± vitamin C treatment (maternal 200 mg.kg −1 IV daily) for the last third of gestation. In one cohort, the maternal arterial blood gas status, the value at which 50% of the maternal hemoglobin is saturated with oxygen (P 50 ), nitric oxide (NO) bioavailability, oxidative stress, and antioxidant capacity were determined. In another, naturally delivered offspring were raised under normoxia until early adulthood (9 months). Lambs were chronically instrumented and cardiovascular function tested in vivo. Following euthanasia, femoral arterial segments were isolated and endothelial function determined by wire myography. Hypoxic pregnancy induced fetal growth restriction and fetal oxidative stress. At adulthood, it programmed hypertension by enhancing vasoconstrictor reactivity and impairing NO-independent endothelial function. Maternal vitamin C in hypoxic pregnancy improved transplacental oxygenation and enhanced fetal antioxidant capacity while increasing NO bioavailability, offsetting constrictor hyper-reactivity and replenishing endothelial function in the adult offspring. These discoveries provide novel insight into mechanisms and interventions against fetal growth restriction and adult-onset programmed hypertension in an animal model of complicated pregnancy in a species of similar temporal developmental milestones to humans.

Original languageEnglish
Article numbere2006552
Number of pages27
JournalPLoS Biology
Volume17
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019
Externally publishedYes

Cite this

Brain, K. L., Allison, B. J., Niu, Y., Cross, C. M., Itani, N., Kane, A. D., ... Giussani, D. A. (2019). Intervention against hypertension in the next generation programmed by developmental hypoxia. PLoS Biology, 17(1), [e2006552]. https://doi.org/10.1371/journal.pbio.2006552
Brain, Kirsty L. ; Allison, Beth J. ; Niu, Youguo ; Cross, Christine M. ; Itani, Nozomi ; Kane, Andrew D. ; Herrera, Emilio A. ; Skeffington, Katie L. ; Botting, Kimberley J. ; Giussani, Dino A. / Intervention against hypertension in the next generation programmed by developmental hypoxia. In: PLoS Biology. 2019 ; Vol. 17, No. 1.
@article{64a07da1caa5491e91f3095e90669547,
title = "Intervention against hypertension in the next generation programmed by developmental hypoxia",
abstract = "Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans share similar precocial developmental milestones in cardiovascular anatomy and physiology. We tested the hypothesis in sheep that maternal treatment with antioxidants protects against fetal growth restriction and programmed hypertension in adulthood in gestation complicated by chronic fetal hypoxia, the most common adverse consequence in human pregnancy. Using bespoke isobaric chambers, chronically catheterized sheep carrying singletons underwent normoxia or hypoxia (10{\%} oxygen [O 2 ]) ± vitamin C treatment (maternal 200 mg.kg −1 IV daily) for the last third of gestation. In one cohort, the maternal arterial blood gas status, the value at which 50{\%} of the maternal hemoglobin is saturated with oxygen (P 50 ), nitric oxide (NO) bioavailability, oxidative stress, and antioxidant capacity were determined. In another, naturally delivered offspring were raised under normoxia until early adulthood (9 months). Lambs were chronically instrumented and cardiovascular function tested in vivo. Following euthanasia, femoral arterial segments were isolated and endothelial function determined by wire myography. Hypoxic pregnancy induced fetal growth restriction and fetal oxidative stress. At adulthood, it programmed hypertension by enhancing vasoconstrictor reactivity and impairing NO-independent endothelial function. Maternal vitamin C in hypoxic pregnancy improved transplacental oxygenation and enhanced fetal antioxidant capacity while increasing NO bioavailability, offsetting constrictor hyper-reactivity and replenishing endothelial function in the adult offspring. These discoveries provide novel insight into mechanisms and interventions against fetal growth restriction and adult-onset programmed hypertension in an animal model of complicated pregnancy in a species of similar temporal developmental milestones to humans.",
author = "Brain, {Kirsty L.} and Allison, {Beth J.} and Youguo Niu and Cross, {Christine M.} and Nozomi Itani and Kane, {Andrew D.} and Herrera, {Emilio A.} and Skeffington, {Katie L.} and Botting, {Kimberley J.} and Giussani, {Dino A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1371/journal.pbio.2006552",
language = "English",
volume = "17",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "1",

}

Brain, KL, Allison, BJ, Niu, Y, Cross, CM, Itani, N, Kane, AD, Herrera, EA, Skeffington, KL, Botting, KJ & Giussani, DA 2019, 'Intervention against hypertension in the next generation programmed by developmental hypoxia', PLoS Biology, vol. 17, no. 1, e2006552. https://doi.org/10.1371/journal.pbio.2006552

Intervention against hypertension in the next generation programmed by developmental hypoxia. / Brain, Kirsty L.; Allison, Beth J.; Niu, Youguo; Cross, Christine M.; Itani, Nozomi; Kane, Andrew D.; Herrera, Emilio A.; Skeffington, Katie L.; Botting, Kimberley J.; Giussani, Dino A.

In: PLoS Biology, Vol. 17, No. 1, e2006552, 01.01.2019.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Intervention against hypertension in the next generation programmed by developmental hypoxia

AU - Brain, Kirsty L.

AU - Allison, Beth J.

AU - Niu, Youguo

AU - Cross, Christine M.

AU - Itani, Nozomi

AU - Kane, Andrew D.

AU - Herrera, Emilio A.

AU - Skeffington, Katie L.

AU - Botting, Kimberley J.

AU - Giussani, Dino A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans share similar precocial developmental milestones in cardiovascular anatomy and physiology. We tested the hypothesis in sheep that maternal treatment with antioxidants protects against fetal growth restriction and programmed hypertension in adulthood in gestation complicated by chronic fetal hypoxia, the most common adverse consequence in human pregnancy. Using bespoke isobaric chambers, chronically catheterized sheep carrying singletons underwent normoxia or hypoxia (10% oxygen [O 2 ]) ± vitamin C treatment (maternal 200 mg.kg −1 IV daily) for the last third of gestation. In one cohort, the maternal arterial blood gas status, the value at which 50% of the maternal hemoglobin is saturated with oxygen (P 50 ), nitric oxide (NO) bioavailability, oxidative stress, and antioxidant capacity were determined. In another, naturally delivered offspring were raised under normoxia until early adulthood (9 months). Lambs were chronically instrumented and cardiovascular function tested in vivo. Following euthanasia, femoral arterial segments were isolated and endothelial function determined by wire myography. Hypoxic pregnancy induced fetal growth restriction and fetal oxidative stress. At adulthood, it programmed hypertension by enhancing vasoconstrictor reactivity and impairing NO-independent endothelial function. Maternal vitamin C in hypoxic pregnancy improved transplacental oxygenation and enhanced fetal antioxidant capacity while increasing NO bioavailability, offsetting constrictor hyper-reactivity and replenishing endothelial function in the adult offspring. These discoveries provide novel insight into mechanisms and interventions against fetal growth restriction and adult-onset programmed hypertension in an animal model of complicated pregnancy in a species of similar temporal developmental milestones to humans.

AB - Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans share similar precocial developmental milestones in cardiovascular anatomy and physiology. We tested the hypothesis in sheep that maternal treatment with antioxidants protects against fetal growth restriction and programmed hypertension in adulthood in gestation complicated by chronic fetal hypoxia, the most common adverse consequence in human pregnancy. Using bespoke isobaric chambers, chronically catheterized sheep carrying singletons underwent normoxia or hypoxia (10% oxygen [O 2 ]) ± vitamin C treatment (maternal 200 mg.kg −1 IV daily) for the last third of gestation. In one cohort, the maternal arterial blood gas status, the value at which 50% of the maternal hemoglobin is saturated with oxygen (P 50 ), nitric oxide (NO) bioavailability, oxidative stress, and antioxidant capacity were determined. In another, naturally delivered offspring were raised under normoxia until early adulthood (9 months). Lambs were chronically instrumented and cardiovascular function tested in vivo. Following euthanasia, femoral arterial segments were isolated and endothelial function determined by wire myography. Hypoxic pregnancy induced fetal growth restriction and fetal oxidative stress. At adulthood, it programmed hypertension by enhancing vasoconstrictor reactivity and impairing NO-independent endothelial function. Maternal vitamin C in hypoxic pregnancy improved transplacental oxygenation and enhanced fetal antioxidant capacity while increasing NO bioavailability, offsetting constrictor hyper-reactivity and replenishing endothelial function in the adult offspring. These discoveries provide novel insight into mechanisms and interventions against fetal growth restriction and adult-onset programmed hypertension in an animal model of complicated pregnancy in a species of similar temporal developmental milestones to humans.

UR - http://www.scopus.com/inward/record.url?scp=85060381458&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.2006552

DO - 10.1371/journal.pbio.2006552

M3 - Article

VL - 17

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 1

M1 - e2006552

ER -